Efficacy of the natural oxygen transporter HEMO 2 life ® in cold preservation in a preclinical porcine model of donation after cardiac death
- 29 March 2019
- journal article
- research article
- Published by Frontiers Media SA in Transplant International
- Vol. 32 (9) , 985-996
Abstract
The growing use of marginal organs for transplantation pushes current preservation methods towards their limits, and the need for improvement is pressing. We previously demonstrated the benefits of M101, a natural extracellular oxygen carrier compatible with hypothermia, for the preservation of healthy renal grafts in a porcine model of auto‐transplantation. Herein, we use a variant of this pre‐clinical model to evaluate M101 potential benefits both in static storage (CS) and in machine perfusion (MP) preservation in the transplantation outcomes for marginal kidneys. In the CS arm, despite the absence of obvious benefits within the first two weeks of follow‐up, M101 dose‐dependently improved long‐term function, normalizing creatininemia after 1 and 3 months. In the MP arm, M101 improved short and long‐term functional outcomes as well as tissue integrity. Importantly, we provide evidence for the additivity of machine perfusion and M101 functional effects, showing that the addition of the compound further improves organ preservation, by reducing short‐term function loss, with no loss of function or tissue integrity recorded throughout the follow‐up. Extending previous observations with healthy kidneys, the present results point at the M101 oxygen carrier as a viable strategy to improve current organ preservation methods in marginal organ transplantation.Keywords
Funding Information
- Agence Nationale de la Recherche (RPIB‐013, 2011)
This publication has 31 references indexed in Scilit:
- Benefits of active oxygenation during hypothermic machine perfusion of kidneys in a preclinical model of deceased after cardiac death donorsJournal of Surgical Research, 2013
- Contribution of Large Pig for Renal Ischemia‐Reperfusion and Transplantation Studies: The Preclinical ModelBioMed Research International, 2011
- Protective Effect of Lifor Solution in Experimental Renal Ischemia-Reperfusion InjuryJournal of Surgical Research, 2010
- Machine Perfusion Versus Cold Storage for the Preservation of Kidneys Donated After Cardiac DeathAnnals of Surgery, 2010
- Thrombin Inhibition During Kidney Ischemia-Reperfusion Reduces Chronic Graft Inflammation and Tubular AtrophyTransplantation, 2010
- Anti-thrombin Therapy During Warm Ischemia and Cold Preservation Prevents Chronic Kidney Graft Fibrosis in a DCD ModelAmerican Journal of Transplantation, 2009
- Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal diseaseLaboratory Investigation, 2009
- Short- and Long-Term Outcomes with the Use of Kidneys and Livers Donated after Cardiac DeathAmerican Journal of Transplantation, 2007
- Arenicola marina extracellular hemoglobin: a new promising blood substituteBiotechnology Journal, 2006
- Perfluorocarbon for organ preservation before transplantation1Transplantation, 2002